June 2026 Research Update

This month brought direct clinical evidence that added oxygen during sleep can meaningfully reduce central sleep apnea in very young children with Prader-Willi syndrome, at least during a monitored overnight test. The key pattern was improvement in breathing pauses and oxygen levels, without signals of worse carbon dioxide retention or disturbed sleep during that night. This helps sharpen the picture that some sleep-related breathing problems in Prader-Willi syndrome can respond to simple supportive measures, though the study was small. [1]

In 10 growth hormone-naive infants under age 2 with central sleep apnea, supplemental oxygen was compared with medical air during an overnight sleep study. Oxygen reduced the central apnea-hypopnea index (the number of central events per hour) and improved oxygen saturation measures, while sleep stages and obstructive events stayed similar between conditions. The study also measured skin carbon dioxide and did not see clinically meaningful hypercapnia. [1]

For families dealing with central sleep apnea in infancy, this study adds near-term, practical information: during a supervised overnight sleep test, oxygen improved breathing stability and oxygen levels without clear short-term safety problems. Because the evidence comes from only 10 infants and focuses on a single-night setting, it mainly strengthens understanding of what can work under monitoring rather than answering longer-term questions (such as how durable benefits are at home over months). It also leaves open why oxygen helped (oxygen level itself versus airflow effects), which matters for designing future studies and devices. [1]

Several studies this month focused on how Prader-Willi syndrome is measured in real life, from body composition to daily well-being to how reliably health records capture the diagnosis. Together, they point to two practical ideas: low muscle mass is common and may be screenable with simpler tools, and everyday quality of life varies in ways that connect to age and food-related behaviors. A separate health-record study suggests that when Prader-Willi syndrome is coded in the chart, it is usually correct, which matters for research that uses medical records. [2] [3] [4]

In 48 people with genetically confirmed Prader-Willi syndrome in Taiwan, ultrasound thickness of a calf muscle (gastrocnemius medialis) tracked reasonably well with a DXA scan estimate of limb muscle mass. Using ultrasound as a screening approach, low muscle mass and sarcopenia (low muscle with low strength) were both reported as common in this group, alongside universal obesity in the sample. This supports the idea that muscle health may be measurable without radiation, although the study did not establish norms specific to Prader-Willi syndrome. [2]

In Japan, proxy reports for 119 adolescents and adults with Prader-Willi syndrome showed a median health-related quality of life score of 0.665 on a standard questionnaire. Higher quality of life was more likely in those ages 16 to 19, in those with the deletion genetic subtype, and in those reported to have fewer problematic food-related behaviors. This connects quality of life to day-to-day challenges around food, and it also suggests that the transition from later teens into adulthood may be a sensitive period for well-being. [3]

A large electronic health record study checked how well the ICD-10 code Q87.11 identifies true Prader-Willi syndrome. When a patient had at least one Q87.11 code, the positive predictive value was high (96.8%), meaning most coded patients truly had Prader-Willi syndrome on chart review. The study also found outpatient encounter sensitivity was lower than inpatient, which matters for studies that rely on visit-by-visit coding rather than patient-level diagnosis. [4]

These findings mainly add clarity about tracking Prader-Willi syndrome, rather than introducing new treatments. Muscle ultrasound could become a more convenient way to flag low muscle mass, but it is not yet a finalized standard for Prader-Willi syndrome and was studied in one population. The quality-of-life survey helps put numbers to lived experience and points to food-related behaviors and life stage as areas strongly connected to how people are doing, even though it cannot prove what causes changes in well-being. The health-record coding study mostly matters for future research quality, because it suggests many coded patients in that health system are correctly identified as having Prader-Willi syndrome. [2] [3] [4]

This month added detail about how Prader-Willi syndrome affects families and also shared a small set of individual clinical stories that may not generalize. Across the larger family studies, the consistent message was that emotional and social factors in the household matter: loneliness related to heavier caregiver burden, and siblings often described lasting effects on stress levels and their own relationship with food. The case reports broadened the range of situations clinicians and families may encounter, from complex genetic testing results to managing severe obesity and difficult repetitive behaviors. [5] [6] [7] [8] [9] [10]

In a survey of 1,105 parent caregivers of children with Prader-Willi syndrome in mainland China, higher loneliness scores went along with higher reported caregiving burden. The study also reported that family functioning buffered this relationship, meaning loneliness had a weaker link to burden when family functioning scores were higher. The relationship between loneliness and burden was reported as stronger at higher socioeconomic status than at lower socioeconomic status, a result that may reflect different expectations or pressures but was not explained by the study. [5]

Interviews with 25 siblings in North America described a mix of coping and strain while growing up with a sibling with Prader-Willi syndrome. Many described being highly focused on food themselves, and a small number reported being diagnosed with an eating disorder. Siblings also described social and emotional impacts, such as stress, embarrassment in public situations, and feeling overlooked, alongside potential supports like connection with other siblings of people with Prader-Willi syndrome and more PWS-specific education. [6]

Several single-patient reports described situations that are important mainly as examples rather than proof of what usually works. One prenatal case showed that different genetic tests can give discordant results in an atypical situation, and methylation testing (MLPA methylation analysis) was needed to confirm hypermethylation in the Prader-Willi region. This case highlights that rare genetic pathways can complicate early testing and may affect how confidently a diagnosis is confirmed. [7]

A separate adult case report described laparoscopic sleeve gastrectomy in a 24-year-old man with Prader-Willi syndrome and very high body weight, with an uneventful short-term recovery and substantial weight loss reported at 6 months. The paper emphasized careful selection and the role of multidisciplinary follow-up and supplementation, while noting uncertainty about long-term outcomes. This adds to the picture that bariatric surgery has been attempted in Prader-Willi syndrome but is complex and not represented by large comparative trials in this summary. [8]

Another case report focused on severe compulsive scratching in a 19-year-old woman with Prader-Willi syndrome. Escitalopram was sedating and only partly helpful; vortioxetine helped more, and adding lurasidone was followed by marked, durable reduction in scratching over 2 years in that individual. Because this is a single case without a control, it cannot show which medication (or combination) was responsible or how often this would happen in others. [9]

A small case series on obesity and the growth hormone and IGF-1 system included one person with Prader-Willi syndrome who received dulaglutide, reporting weight loss and reduced insulin requirements in that individual. The paper used these cases to propose a way of thinking about hormone networks in obesity, but it did not test a treatment approach in a larger Prader-Willi syndrome group. This makes it most useful as an early signal and a hypothesis for future research rather than a generalizable result. [10]

For many families, the strongest immediate value here is validation that emotional strain is measurable and common, and that family and social supports may shape how heavy caregiving feels, even though the studies cannot prove cause and effect. The sibling interviews also clarify that siblings may need their own support around stress and food-related concerns, but the findings come from a small North American group and may not fit every family. The case reports are best read as real-world examples that expand awareness of possible diagnostic complexities and management approaches, but they are early evidence and do not tell how likely similar outcomes are for others. [5] [6] [7] [8] [9] [10]

One study this month explored possible heart-related biology using a mouse model tied to a gene in the Prader-Willi region. The main pattern was subtle but measurable changes in heart structure and pumping function, plus male-specific changes in atrial electrical currents that could matter for rhythm risk in theory. Because this is animal research, it does not show that the same heart changes occur in people with Prader-Willi syndrome, but it helps define specific mechanisms that future human studies could check. [11]

Magel2 knockout mice showed concentric remodeling of the left ventricle with reduced chamber volumes, and the ejection fraction was modestly lower than in wild-type mice. In male mice, atrial cells had shorter action potentials and much higher TASK-1 potassium currents, while female mice did not show the same electrophysiology differences. The study also reported that older knockout mice had obesity and worse blood sugar control markers, which could contribute to heart effects in complex ways. [11]

This study matters mainly for longer-term research because it points to concrete heart measurements and electrical pathways that may be worth checking in people with Prader-Willi syndrome. It does not provide a new test or treatment for patients now, and it cannot predict an individual person's heart risks. What it adds is a clearer set of biological questions, including why males and females might differ, and how metabolism and heart function could be linked in this genetic context. [11]